conference reports
Polymorphisms in specific genes might influence prostate cancer risk
Wednesday, 10 December 2008- Researchers M. Gos et al. presented at the EAU 8th Central European Meeting in Warsaw, their study titled "Polymorphisms in specific genes might influence prostate cancer risk in Polish population as...
Edited by: FGR
Quality of life before and one year after radical prostatectomy
Tuesday, 9 December 2008 - Radical surgical treatment for patients with prostate cancer has positive impact on self-support and social relations, according to a study D. Milonas and A. Blazeviciene presented during the EAU...
Edited by: FGR
Circulating MicroRNAs as stable blood-based markers for cancer
Monday, 8 December 2008- Dr. Muneesh Tewari from Fred Hutchinson Cancer Center at the University of Washington concluded that MIR-141 is a cancer-associated microRNA. He shared his research results on the characterisation of this...
Edited by: JV
Temperature-enhanced metastatic therapy for prostate cancer
Friday, 5 December 2008 - Lead investigator Prof. Robert Getzenberg, urology and molecular science professor at the Johns Hopkins University in Baltimore, Maryland (USA), discussed his preliminary findings on temperature-enhanced...
Edited by: JV
Additional immune checkpoints in prostate cancer: PD-1 and LAG-3
Wednesday, 3 December 2008 - At the Prostate Cancer Foundation (PCF) 15th Annual Scientific Retreat held at Incline Village, Nevada, USA, Dr. Charles Drake from Johns Hopkins presented new information on immune...
Edited by: JV
Circulating prostate tumour cells and Micro Electronic Machines
Tuesday, 2 December 2008 - At the Prostate Cancef Foundation (PCF) 15th Annual Scientific Retreat held at Incline Village, Nevada, USA, Dr. Daniel Haver and Mehmet Toner of the Massachusetts General Hospital Cancer Center...
Edited by: JV
Future prospects in cancer genome research
Monday, 1 December 2008 - Complete sequencing of the three billion genetic letters in the genome of a cancer patient will soon be a practical reality. At the recent Prostate Cancer Foundation (PCF) 15th Annual Scientific...
Edited by: JV
Prostate-cancer-targeted nanoparticles study to spur new treatment strategies
Friday, 28 November 2008- Prostate-cancer-targeted nanoparticles loaded with anti-tumour drugs like taxotere are among the awaited new treatment strategies that can deliver far higher drug doses to tumour cells without...
Edited by: JV
PSA serum evaluation for prostate cancer screening makes no sense in industrial areas
Wednesday, 26 November 2008 - At the EAU 4th South Eastern European Meeting held in Albania, D. Galiopoulos, T. Lambou, et al. did not find current evidence supporting the usefulness of PSA serum evaluation for the screening...
Edited by: FGR
Morphologic MR with 3D spectroscopy MR is helpful in early PCa diagnosis
Monday, 24 November 2008- At the 8th EAU Central European Meeting S. Bak et al. compared morphologic MR with 3D spectroscopy MR. “We receive additional information about prostate cancer and we are able to localize prostate cancer...
Edited by: FGR
